Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹482 Cr | ₹8459 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 11 Dec 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.39 | 1.82 |
| Manager | Abhishek Bisen | Sailesh Raj Bhan |
| ISIN Code | INF174KA1PW4 | INF204K01968 |
| Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 0.56% | 1.08% |
| 6 Month | -0.29% | -0.29% |
| 1 Year | -5.37% | -1.7% |
| 3 Year | - | 22.74% |
| 5 Year | - | 15.11% |
SIP Return Analysis
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -0.93% | -0.23% |
| 1 Year | 3.57% | 4.86% |
| 3 Year | - | 15.43% |
| 5 Year | - | 15.72% |
Rolling Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 9.37% | 16.54% |
| 3 Year | - | 20.99% |
| 5 Year | - | 20.35% |
Risk Management
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.98% |
| Beta | - | 0.87% |
| Alpha | - | 1.45% |
Fund Managers
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Abhishek Bisen | Sailesh Raj Bhan |
| Total AUM | ₹0 Cr | ₹96086 Cr |
| Funds Managed | 33 | 5 |
| Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.97 | 3.47 |
| Small Cap | 36.06 | 29.97 |
| Large Cap | 47.07 | 32.01 |
| Mid Cap | 15.9 | 34.55 |
Sector Allocation
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 0.97 | 2.63 |
| Pharmaceuticals & Biotechnology | 71.51 | - |
| Healthcare Services | 25.8 | - |
| Healthcare Equipment & Supplies | 1.72 | - |
| Healthcare | - | 97.37 |
Top Comparisons
HDFC Manufacturing Fund - Regular (G)
3Y Returns0%
NIPPON INDIA MONTHLY INTERVAL FUND SERIES I REGULAR PLAN GROWTH
3Y Returns5.92%
Mahindra Manulife Mid Cap Fund - Regular Plan - Growth
3Y Returns25.35%
SBI Midcap Fund - Regular Plan - Growth
3Y Returns18.44%
Mirae Asset Short Duration Fund- Regular Plan -Growth
3Y Returns7.04%
UTI Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.33%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns%